World Health Organization Selects ISCT Journal Cytotherapy® to Publish Novel ATMP Official Nomenclature Initiative
Official INN assignments to provide proper classification for ATMPs, ensuring safe dispensing and identification by healthcare providers
Vancouver, Canada, April 6, 2021 - The International Society for Cell & Gene Therapy (ISCT), the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated to the translation of cell and gene therapy into safe and effective therapies to improve patients’ lives, today announces that the World Health Organization (WHO) has selected ISCT’s official journal Cytotherapy® to publish a landmark reference document on nomenclature in advanced therapy medicinal products (ATMPs). To achieve the aims set out in the initiative, Massimo Dominici, a former President for ISCT, has been appointed to the WHO Expert Advisory Panel on The International Pharmacopoeia and Pharmaceutical Preparations, serving the International Nonproprietary Names (INN) Expert Group.
Click here to read more#News